Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21127,858,0.98 [0.91-1.05],0.5317791981973781
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,168,0.90 [0.77-1.05],0.190459316821141
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22810,172,0.95 [0.82-1.10],0.4997011312942011
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16092,642,0.94 [0.87-1.02],0.1650219420774165
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22749,111,0.85 [0.71-1.02],0.0826844515314931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21848,76,0.91 [0.72-1.13],0.3904195213852089
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23959,110,0.86 [0.71-1.03],0.1037915843216833
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23952,73,0.93 [0.74-1.17],0.5355464600743371
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21301,52,0.88 [0.67-1.16],0.3716329084066327
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23403,105,0.94 [0.77-1.13],0.4967346736462207
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23363,65,0.86 [0.68-1.10],0.2273905316223694
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24029,68,0.97 [0.77-1.23],0.8261252438949716
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other viral diseases,24002,85,0.95 [0.76-1.17],0.6057716278725572
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23999,82,0.95 [0.76-1.18],0.6349964348168035
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Mycoses,23710,56,1.01 [0.78-1.31],0.9399010128050524
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23012,371,0.99 [0.89-1.10],0.8394030856619185
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22758,117,1.04 [0.86-1.24],0.6919527415655451
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22894,253,1.02 [0.90-1.16],0.7382546176519653
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19641,44,0.83 [0.62-1.12],0.2153029798599539
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19653,56,nan [nan-nan],
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19825,228,0.97 [0.85-1.11],0.7022190695915931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19832,235,0.97 [0.85-1.11],0.6443493143435568
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20182,585,0.98 [0.90-1.07],0.6443706559568325
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19645,48,0.96 [0.72-1.27],0.7672885949692918
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21588,894,1.05 [0.98-1.13],0.134545567762192
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23115,256,1.06 [0.94-1.20],0.3380759333224465
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23731,100,1.04 [0.85-1.27],0.6877933226487803
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24112,81,0.95 [0.76-1.18],0.6309282254927921
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Rectum,23928,53,1.45 [1.10-1.90],0.0078036906415129
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24109,59,0.83 [0.64-1.07],0.150971025458336
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Stomach,24154,45,0.89 [0.66-1.19],0.4339065918981982
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm,23962,243,0.92 [0.82-1.05],0.2247580946132318
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24111,100,0.91 [0.75-1.11],0.3365219523776476
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24109,93,0.95 [0.77-1.16],0.5864521687569824
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24044,62,0.94 [0.73-1.20],0.5976594005757648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma, any site",24046,61,0.96 [0.75-1.23],0.7530725459344748
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi,23961,234,1.10 [0.97-1.26],0.1337402885600921
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24112,111,1.26 [1.04-1.52],0.0178395796482301
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Other benign neoplasms of skin,24014,199,1.09 [0.95-1.26],0.205950677035448
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of breast,24095,121,0.94 [0.79-1.12],0.4820403716342754
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Leiomyoma of uterus,23665,885,1.02 [0.96-1.09],0.5230044309310891
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22965,237,1.06 [0.93-1.20],0.3810742204037456
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22730,388,1.10 [0.99-1.21],0.069957149665095
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22730,388,1.10 [0.99-1.21],0.069957149665095
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21393,350,0.96 [0.86-1.07],0.4674851335654481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23633,87,0.91 [0.74-1.12],0.3700314601798525
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23856,86,0.92 [0.75-1.14],0.4658826851219686
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20065,773,1.05 [0.98-1.14],0.1621051857426106
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22163,771,1.02 [0.95-1.10],0.5688132701608657
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22539,95,0.90 [0.74-1.10],0.2980593916786112
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23262,48,0.93 [0.70-1.23],0.5905058475034688
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22529,85,0.97 [0.78-1.20],0.7620285724560433
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22800,356,1.13 [1.01-1.26],0.0317212541952061
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22790,346,1.14 [1.02-1.27],0.0211907957549393
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22368,160,0.93 [0.79-1.10],0.3984356755324494
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22370,157,0.94 [0.79-1.12],0.4834948233320705
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19895,603,1.06 [0.97-1.15],0.20651109714323
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19361,69,1.04 [0.82-1.32],0.760974173514674
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19854,562,1.05 [0.96-1.15],0.2618549703368144
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19340,48,1.08 [0.81-1.44],0.6052573635179587
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19351,59,1.02 [0.79-1.33],0.8588751140414799
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Any mental disorder,20392,526,0.97 [0.89-1.06],0.5435324333722511
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19967,101,0.91 [0.74-1.11],0.3417556332377715
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23938,65,0.83 [0.65-1.06],0.1372822666282943
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23974,39,0.75 [0.55-1.02],0.0680467699939609
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22892,33,0.89 [0.63-1.26],0.52722320146508
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24111,33,0.89 [0.63-1.25],0.4912520457176171
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19899,33,0.90 [0.63-1.27],0.5388484021201384
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Alcohol dependence,22883,24,0.68 [0.46-1.02],0.0632551964257467
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Smoking dependency,22806,32,0.93 [0.65-1.34],0.7039953738524437
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19905,39,0.89 [0.65-1.22],0.4695379888734168
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20188,322,0.99 [0.89-1.11],0.879148337838638
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Depression,22401,288,0.97 [0.86-1.09],0.604926147358162
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Depression or dysthymia,20008,250,1.03 [0.91-1.17],0.6107561286702141
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19996,130,1.02 [0.86-1.21],0.840352415001181
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Other anxiety disorders,22488,65,0.85 [0.67-1.08],0.1856250541169952
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Neurological diseases,20920,1424,1.04 [0.99-1.10],0.123703711058616
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19145,170,1.01 [0.87-1.17],0.9041621884995296
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23981,140,1.03 [0.87-1.22],0.7373557984082081
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23007,370,1.00 [0.90-1.11],0.9737396675806528
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Epilepsy,22753,116,0.99 [0.83-1.19],0.9453737887129248
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Migraine,22749,112,1.07 [0.88-1.28],0.5067216863005792
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23764,104,1.07 [0.88-1.30],0.4957856094795959
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23547,51,1.16 [0.88-1.53],0.2951032529579107
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other sleep disorders,22724,87,0.88 [0.71-1.08],0.2241348746280871
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Sleep apnoea,23797,62,0.93 [0.73-1.19],0.5722759853813577
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22948,731,1.04 [0.96-1.12],0.3198037271178749
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22319,102,1.01 [0.84-1.23],0.8849571560175015
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22677,460,1.05 [0.96-1.15],0.2899630712815257
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23933,67,1.17 [0.92-1.49],0.2099470635847763
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Hemiplegia,23917,51,1.11 [0.85-1.47],0.4428639687428772
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other neurological diseases,23732,105,0.93 [0.77-1.12],0.447122163718489
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23517,381,0.99 [0.89-1.10],0.8445305252430834
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23356,220,1.04 [0.91-1.18],0.6034403310400303
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23201,65,0.85 [0.66-1.08],0.1743978840821375
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23252,116,1.12 [0.93-1.35],0.2339043051745597
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23230,94,1.13 [0.92-1.39],0.2307473502884912
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20499,153,0.93 [0.79-1.10],0.3970283127139135
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20713,367,1.01 [0.91-1.12],0.847031357744524
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23245,155,0.95 [0.81-1.12],0.5460666052711067
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23928,29,0.85 [0.60-1.23],0.3940398528714226
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1550,29,0.82 [0.57-1.18],0.287920588959235
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22407,29,0.86 [0.60-1.24],0.4225522644207928
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23540,82,1.00 [0.80-1.24],0.9942691551195612
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23502,44,1.21 [0.90-1.63],0.2171014687454184
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23411,78,0.96 [0.77-1.20],0.7409137436844844
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23647,91,0.92 [0.75-1.13],0.4111779756525279
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24041,111,1.06 [0.88-1.27],0.570513359679421
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23459,97,1.03 [0.84-1.26],0.7773779867867249
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17759,2413,1.04 [0.99-1.09],0.1362262959278173
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23662,69,0.88 [0.69-1.11],0.2783512183597373
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, essential",18676,1768,1.05 [1.00-1.11],0.0499743485445384
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertension,18692,1784,1.05 [1.00-1.11],0.0642518944388627
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16942,34,0.77 [0.55-1.09],0.1388906653251471
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22688,618,1.05 [0.96-1.14],0.2827493195288678
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Angina pectoris,22498,428,1.03 [0.93-1.13],0.615867212915104
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23571,124,1.01 [0.85-1.21],0.8994012200071331
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23638,191,1.04 [0.90-1.20],0.5976895577564192
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24092,24,1.16 [0.78-1.73],0.4652939482323114
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22150,80,1.07 [0.86-1.34],0.532081661616406
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22459,400,1.08 [0.97-1.19],0.1437000896089632
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23453,87,1.11 [0.89-1.37],0.349786485335264
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23555,189,1.11 [0.96-1.28],0.169597772244798
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23458,92,0.80 [0.66-0.99],0.0362151632448454
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23458,92,0.80 [0.66-0.99],0.0362151632448454
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16997,89,0.84 [0.68-1.03],0.0920631920522552
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21024,33,1.02 [0.72-1.44],0.9171829158759957
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Conduction disorders,21056,65,1.12 [0.87-1.43],0.3792652373940254
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14518,88,0.97 [0.78-1.19],0.7516057469758531
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14669,239,0.91 [0.80-1.03],0.1412050311362344
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other arrhythmias,21035,44,1.00 [0.75-1.35],0.9773951083955118
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21041,50,0.77 [0.58-1.01],0.0552103954617809
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23439,88,1.10 [0.89-1.36],0.3896504693522095
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23473,115,0.97 [0.81-1.16],0.7236802284026478
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23509,86,0.97 [0.78-1.20],0.7576881210660369
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23570,74,0.97 [0.77-1.22],0.7894761765668736
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23285,60,0.91 [0.71-1.18],0.481749300602371
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23319,94,0.84 [0.69-1.03],0.0864947946679815
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22749,113,1.16 [0.96-1.39],0.1313733014995312
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22726,90,1.18 [0.96-1.46],0.1223869285876994
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23964,89,1.19 [0.97-1.48],0.0985878690878541
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Varicose veins,23174,538,0.90 [0.83-0.98],0.0188611469100185
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypotension,23197,75,0.92 [0.74-1.16],0.4866925743082597
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19640,1843,1.04 [0.99-1.09],0.1164614458666887
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23959,114,1.01 [0.84-1.22],0.8977786938669132
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Influenza and pneumonia,22746,178,0.95 [0.82-1.10],0.5154507211436884
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22731,163,0.97 [0.83-1.14],0.7365837664711583
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23351,203,0.95 [0.83-1.09],0.4947622769279343
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23347,199,0.95 [0.83-1.10],0.4964008121962199
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23482,493,1.05 [0.96-1.15],0.2443723725289155
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic sinusitis,23093,104,1.15 [0.94-1.39],0.1710892212753527
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Nasal polyp,23061,72,1.10 [0.87-1.39],0.4236739104874802
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23301,312,1.06 [0.94-1.18],0.3351677823245743
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Deviated nasal septum,23110,121,1.02 [0.85-1.22],0.8364632241713748
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11604,57,1.02 [0.78-1.33],0.8937292850977481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21545,1017,1.03 [0.96-1.09],0.4079322768903948
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Early onset COPD,23245,136,1.13 [0.95-1.34],0.1765643123753146
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23262,153,1.06 [0.90-1.25],0.4634338544168955
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23262,153,1.06 [0.90-1.25],0.4634338544168955
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22326,874,1.01 [0.94-1.08],0.7817988646568763
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Asthma,17955,874,1.01 [0.95-1.09],0.6802241239652074
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17794,874,1.02 [0.95-1.09],0.6500797041252874
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17944,863,1.01 [0.94-1.08],0.7568602154535481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23868,77,0.99 [0.79-1.24],0.95280582770439
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Interstitial lung disease,22541,59,1.02 [0.79-1.31],0.8950896116342469
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23932,59,1.02 [0.79-1.32],0.865539063793455
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22535,53,0.95 [0.73-1.25],0.723188353429392
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pleural effusion,22542,73,0.96 [0.77-1.21],0.7566871953078661
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of pleura,22636,167,0.96 [0.82-1.12],0.5984203100401433
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23130,81,0.90 [0.73-1.12],0.3613345240801132
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16772,5263,1.01 [0.98-1.05],0.4431494220457753
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23649,420,1.07 [0.97-1.18],0.152362735029178
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24115,91,1.10 [0.89-1.35],0.3745932803225782
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Impacted teeth,24119,82,1.11 [0.89-1.38],0.3499846540484478
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Dental caries,23325,96,0.97 [0.80-1.19],0.79025526628412
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23338,109,1.18 [0.98-1.43],0.0803903424134261
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24106,101,1.11 [0.91-1.35],0.2924069683636253
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23329,100,1.17 [0.96-1.43],0.1149339516649907
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23068,69,0.83 [0.66-1.05],0.1221554620358276
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24028,44,0.80 [0.60-1.07],0.138135268663758
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18285,194,0.90 [0.78-1.03],0.12649051471481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20116,2025,0.99 [0.95-1.04],0.8136346860602681
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophagitis,18350,259,1.16 [1.03-1.32],0.0166954417842793
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18743,652,0.98 [0.91-1.06],0.6535556241671695
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18159,68,1.10 [0.87-1.40],0.4334720687891745
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18213,122,1.10 [0.92-1.32],0.2954586327614644
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophageal obstruction,18126,35,1.05 [0.75-1.48],0.7593674475894268
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastric ulcer,18220,129,0.84 [0.71-1.00],0.0541641671691443
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Duodenal ulcer,18157,66,0.96 [0.76-1.23],0.7628396672756698
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24070,51,0.91 [0.69-1.20],0.5034835142068406
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Chronic gastritis,18207,116,1.05 [0.87-1.26],0.6067991360381684
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18825,734,0.98 [0.91-1.05],0.5660035784704334
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of appendix,24010,132,1.00 [0.84-1.18],0.9715687115728088
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Functional dyspepsia,18594,503,1.01 [0.92-1.10],0.911025266315972
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18241,150,1.02 [0.87-1.21],0.7664932022884167
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24030,126,0.98 [0.82-1.17],0.8407904395356021
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute appendicitis,23987,109,0.97 [0.80-1.17],0.7290849030062443
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Hernia,21630,1056,1.02 [0.96-1.09],0.5436581460108928
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Inguinal hernia,20632,58,0.87 [0.67-1.12],0.2857617809942606
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Umbilical hernia,20641,67,1.19 [0.93-1.52],0.1693435769526394
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ventral hernia,20663,89,0.93 [0.76-1.15],0.5206730821239477
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21420,846,1.03 [0.96-1.11],0.3842569001880231
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23202,798,1.00 [0.93-1.07],0.9827287411282264
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestines,19183,1912,1.02 [0.97-1.07],0.4551023968421467
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23855,58,0.98 [0.76-1.26],0.8570979216993346
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24096,82,1.01 [0.82-1.26],0.9045921121786034
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn disease,22486,82,1.02 [0.82-1.26],0.875071407235846
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22464,60,0.98 [0.76-1.26],0.8880319643727478
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24020,113,1.09 [0.91-1.32],0.3440927531823388
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcerative colitis,22517,113,1.10 [0.91-1.32],0.3306868842454056
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22503,99,1.08 [0.89-1.32],0.4469435947987669
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23083,679,1.00 [0.93-1.08],0.9715978711511052
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23073,669,0.99 [0.92-1.07],0.8585727736453518
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17361,90,1.01 [0.82-1.25],0.9023816819161744
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal stricture,23733,90,1.01 [0.82-1.24],0.9388276484075392
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17327,56,1.00 [0.77-1.30],0.9796275496470056
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17859,588,1.00 [0.92-1.09],0.9998087531269366
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17482,211,1.02 [0.89-1.16],0.8183687537993796
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17608,337,1.08 [0.97-1.20],0.1681746315656161
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Constipation,22686,302,1.06 [0.95-1.19],0.280784124470238
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23700,113,1.00 [0.83-1.21],0.9750714665324156
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17382,111,1.04 [0.86-1.26],0.6628824697839782
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17312,41,0.88 [0.65-1.20],0.4246567050080359
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18049,778,1.02 [0.95-1.09],0.6631140421701305
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestine,17474,203,0.94 [0.82-1.09],0.4255947229526989
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23686,99,1.00 [0.82-1.22],0.9878921984578968
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of liver,23469,87,0.73 [0.59-0.90],0.0029833319883371
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of liver,23426,44,0.89 [0.67-1.20],0.4507864587158147
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22771,752,1.04 [0.96-1.12],0.3261758855673552
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholelithiasis,22646,627,1.04 [0.96-1.12],0.3892281623811584
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholecystitis,22134,115,1.07 [0.89-1.29],0.4707785174785175
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22077,58,1.14 [0.88-1.48],0.3096999714568443
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute pancreatitis,22070,51,1.00 [0.76-1.32],0.9897966458451048
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24011,51,0.99 [0.75-1.31],0.9604885654925284
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of the digestive system,22950,260,1.26 [1.11-1.43],0.0002425871876437
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22780,90,1.30 [1.05-1.60],0.0155231922140051
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Coeliac disease,22767,77,1.26 [1.01-1.58],0.0451200659652795
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22724,34,1.27 [0.90-1.78],0.1709733472319115
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22831,141,1.31 [1.11-1.55],0.0014127919970555
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,GI-bleeding,22823,133,1.33 [1.12-1.58],0.0012993422251343
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21380,1406,0.97 [0.91-1.02],0.2064540841236877
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23742,104,0.98 [0.81-1.19],0.861625504174327
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23756,396,1.00 [0.91-1.10],0.9946527640431644
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22766,596,1.00 [0.93-1.09],0.9149420872608706
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23429,290,0.96 [0.86-1.08],0.5379182802947932
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23203,64,0.94 [0.73-1.20],0.613216762691102
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23325,186,0.95 [0.82-1.09],0.4480407735821961
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23884,77,0.95 [0.76-1.18],0.6299184776993054
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23862,55,0.95 [0.73-1.24],0.7117355920241211
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23849,42,0.85 [0.63-1.15],0.295343568981681
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23923,50,0.85 [0.64-1.12],0.2493962412270368
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23920,47,0.86 [0.64-1.14],0.2884305679984359
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23411,51,1.15 [0.87-1.51],0.3417918176429497
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23667,307,1.00 [0.89-1.12],0.9682271606410878
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22253,83,0.88 [0.71-1.09],0.2471631762062045
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22302,132,0.98 [0.82-1.16],0.8011186050996724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22265,95,1.02 [0.83-1.25],0.8632409962970258
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22395,225,1.03 [0.90-1.18],0.6521973856702843
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22373,203,1.03 [0.89-1.18],0.7032776470479655
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16994,3866,1.02 [0.98-1.06],0.3886974895355152
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18544,2222,1.02 [0.97-1.07],0.4004588600134018
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21680,1175,1.08 [1.02-1.15],0.0096750213771493
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16517,195,1.07 [0.93-1.23],0.3639573332875213
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16778,456,1.00 [0.91-1.10],0.985133713795722
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23648,187,1.09 [0.94-1.26],0.2570279553002667
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23662,172,1.07 [0.92-1.25],0.3672100139763139
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17393,1071,1.06 [0.99-1.13],0.0967171252168147
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19762,1071,1.06 [0.99-1.13],0.0798871852426404
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16334,12,0.73 [0.41-1.30],0.2839129104563601
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23988,12,0.69 [0.39-1.22],0.2060787892825571
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16555,233,0.97 [0.85-1.11],0.692630336005772
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16398,76,1.00 [0.79-1.26],0.993684159391223
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16592,270,1.09 [0.97-1.24],0.1605407362091966
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23970,140,1.21 [1.02-1.44],0.025432781453765
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16741,419,1.08 [0.97-1.19],0.1437397768508851
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16737,415,1.00 [0.91-1.11],0.9483921777858294
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17562,1240,0.99 [0.94-1.05],0.8068376636901221
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16422,100,1.07 [0.88-1.31],0.4934597959032133
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16690,368,0.94 [0.84-1.04],0.2086397687609136
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16390,68,0.88 [0.69-1.12],0.3116945466135531
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16415,93,1.06 [0.86-1.30],0.608425631614647
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16646,324,1.00 [0.90-1.12],0.9907406990068436
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16596,274,0.99 [0.88-1.11],0.8392026493611305
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17989,259,1.01 [0.89-1.14],0.8903352971383
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23408,208,0.93 [0.81-1.07],0.2975253997162413
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23282,82,1.10 [0.88-1.37],0.3972662102255306
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20688,77,0.97 [0.77-1.22],0.8036728256019461
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20888,277,0.92 [0.82-1.04],0.1886727338243301
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21516,905,0.93 [0.87-1.00],0.040170874707893
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20804,193,0.93 [0.80-1.07],0.2840071930806884
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20681,70,0.93 [0.74-1.18],0.5568345898091667
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21329,718,0.93 [0.87-1.01],0.0730988306075193
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20655,44,1.23 [0.91-1.66],0.1821266331815706
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20821,210,0.92 [0.80-1.05],0.227723794553065
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20699,88,0.94 [0.76-1.15],0.5411128484312451
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20689,78,0.97 [0.77-1.21],0.766588520762504
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20742,131,0.83 [0.70-0.99],0.0377412872869719
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20682,71,1.06 [0.84-1.34],0.6197519199522447
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20924,313,0.95 [0.85-1.06],0.3413253075431675
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20848,343,1.05 [0.94-1.17],0.3944744948725674
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20570,65,0.90 [0.70-1.14],0.3828901992859969
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20601,96,0.91 [0.74-1.11],0.3560248082694196
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20629,124,1.25 [1.04-1.49],0.0160144686573725
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20542,37,1.05 [0.76-1.45],0.7831521683225597
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20556,51,1.14 [0.86-1.51],0.3520733907749618
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20543,38,0.97 [0.71-1.34],0.8708046174376696
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20741,236,1.12 [0.99-1.28],0.0795363024369214
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20557,52,1.05 [0.80-1.38],0.7220048990669024
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20562,57,1.11 [0.85-1.44],0.4370294459443278
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20621,116,1.19 [0.99-1.44],0.0583680139047867
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20576,71,0.94 [0.75-1.19],0.6316747085171979
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20984,479,1.07 [0.97-1.17],0.1693718264947638
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20676,171,0.97 [0.83-1.13],0.6820946326154803
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20767,262,1.05 [0.93-1.18],0.4527952272011384
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21728,214,0.91 [0.79-1.04],0.1657009852377978
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21938,424,0.90 [0.81-0.99],0.026401843638674
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21549,35,0.96 [0.69-1.34],0.8101007093451629
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21565,51,0.88 [0.67-1.16],0.3556834245686012
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21608,94,0.89 [0.73-1.09],0.2685608728561574
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19815,5383,0.98 [0.95-1.01],0.1857293277822351
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22118,156,0.93 [0.80-1.09],0.3995066728195755
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22001,39,1.25 [0.91-1.72],0.1705422866085915
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Acute renal failure,22293,27,1.01 [0.69-1.46],0.9772108940381754
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22296,30,0.85 [0.59-1.21],0.356494997938992
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22296,30,0.96 [0.67-1.37],0.8195436695930447
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23937,113,0.95 [0.79-1.14],0.5747167684140622
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23845,54,1.05 [0.80-1.38],0.7093333755901285
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23908,84,0.98 [0.79-1.21],0.8329322217646993
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23857,33,0.95 [0.68-1.34],0.7773097176801931
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22227,1101,0.99 [0.93-1.06],0.8385878491177852
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Cystitis,21235,109,0.92 [0.76-1.11],0.4005403246549733
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21201,75,1.18 [0.94-1.48],0.1653280671535405
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21270,144,1.03 [0.87-1.21],0.7205711563128205
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urethral stricture,21208,82,0.85 [0.69-1.06],0.1529660118339255
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21996,870,1.01 [0.94-1.08],0.7674009037510549
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23883,425,0.93 [0.85-1.02],0.1378205193351231
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23591,133,0.96 [0.81-1.14],0.6596165048958971
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23602,144,0.94 [0.79-1.10],0.4206855575266953
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23564,106,0.88 [0.73-1.07],0.2015579112569683
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23818,487,0.98 [0.90-1.07],0.6791088318461966
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23448,117,0.90 [0.75-1.08],0.2700352877898588
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23546,215,1.03 [0.90-1.18],0.6362748073253388
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22028,4030,0.99 [0.96-1.03],0.5936361990825689
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Endometriosis,18310,312,1.06 [0.95-1.19],0.29399607921368
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,18086,88,1.26 [1.02-1.57],0.0310111282574098
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18144,146,1.03 [0.87-1.21],0.7576060122228684
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18699,701,1.02 [0.95-1.10],0.5804639217081891
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18347,349,0.94 [0.84-1.04],0.2383397584724692
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18835,837,0.95 [0.88-1.02],0.1304892674586801
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Uterine polyps,18271,273,0.84 [0.75-0.95],0.0051774614374234
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18385,387,1.05 [0.95-1.17],0.3150872195127624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,18086,88,1.15 [0.93-1.42],0.184558488315371
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,18165,167,1.08 [0.93-1.26],0.3203233626245376
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",24115,233,1.08 [0.95-1.23],0.2425380250824997
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,24125,221,1.08 [0.95-1.23],0.2508080728657635
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,24145,121,1.13 [0.94-1.35],0.1872247589541525
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",24136,133,1.12 [0.95-1.33],0.1846737012489382
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18125,127,0.91 [0.76-1.08],0.2684009668115866
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18102,104,1.00 [0.82-1.21],0.9697098279482648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18125,127,1.04 [0.87-1.23],0.6896028425996344
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Irregular menses,24054,408,1.11 [1.01-1.23],0.0321878000753367
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19181,1183,1.05 [0.99-1.11],0.1125525958747407
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Menorrhagia,18771,773,1.02 [0.95-1.10],0.5452892222828748
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",24131,176,1.06 [0.92-1.23],0.4139472977091416
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18407,409,0.96 [0.87-1.06],0.4206568041827286
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18272,274,0.97 [0.86-1.10],0.6607834321046033
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18795,797,0.97 [0.90-1.04],0.4107827952381158
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Female infertility,18086,88,1.13 [0.91-1.40],0.2747766999847274
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",18079,81,1.10 [0.88-1.37],0.4072225818977238
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,24141,733,1.01 [0.93-1.10],0.7992280771253022
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24148,1014,1.04 [0.97-1.11],0.3242853482284821
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,24142,395,1.12 [1.01-1.24],0.0325784333611885
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23858,111,1.15 [0.95-1.39],0.1590175032855351
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23904,157,1.03 [0.88-1.21],0.7141014028050716
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23887,140,1.25 [1.05-1.48],0.0123843818139197
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",24158,144,1.00 [0.85-1.18],0.995464198456238
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,24160,141,1.00 [0.85-1.19],0.9815647932322557
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,24157,365,0.95 [0.86-1.06],0.3858587718664085
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23900,108,0.85 [0.70-1.04],0.1090471962780766
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23995,203,0.95 [0.83-1.10],0.5199611535461448
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23533,125,1.09 [0.91-1.30],0.3679090371857878
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23580,172,0.98 [0.84-1.14],0.7864052549597116
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23611,203,0.97 [0.84-1.11],0.6299939566555521
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23530,122,1.05 [0.87-1.25],0.6267680504557507
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",False labour,23523,115,1.07 [0.89-1.29],0.4810805581335466
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23534,126,0.95 [0.80-1.14],0.5996001454432545
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,23326,192,1.11 [0.96-1.29],0.1528328279492496
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23513,379,1.00 [0.90-1.11],0.98982235946496
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23696,562,1.06 [0.97-1.16],0.2171438044505355
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24163,147,1.05 [0.89-1.24],0.5551980676103884
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22934,113,1.03 [0.85-1.24],0.7529699551453866
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",23219,85,0.99 [0.80-1.22],0.9039178509961302
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,24168,289,0.98 [0.87-1.10],0.7061672105427392
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,24102,223,0.95 [0.83-1.09],0.5073733871270346
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",24157,216,1.02 [0.89-1.18],0.7477977308841831
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",24147,206,1.03 [0.89-1.18],0.7254294967491115
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23906,42,0.87 [0.64-1.18],0.3698424949699155
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Falls/tendency to fall,21629,546,0.91 [0.84-0.99],0.0327321055416886
